Literature DB >> 2169557

Antidepressants and brain neurochemistry.

E Richelson1.   

Abstract

Most antidepressant drugs prescribed today have been available for decades. Nonetheless, their mechanism of action in treating depression has remained elusive. On the basis of neurochemical studies in laboratory animals, hypotheses explaining their therapeutic effects have been formulated. The most attractive of these theories involves antidepressant-induced changes in the sensitivity of certain catecholamine and serotonergic receptors in the brain. Support for this hypothesis from clinical studies has been difficult to obtain. Pharmacologic studies of antidepressant drugs, however, indicate the involvement of blockade of neuronal uptake systems for norepinephrine and serotonin and blockade of many receptors for neurotransmitters. These properties of antidepressants can explain some of their adverse effects and certain interactions with other drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169557     DOI: 10.1016/s0025-6196(12)62747-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

Review 1.  Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.

Authors:  P Mourilhe; P E Stokes
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 2.  Primary headache disorders and neuro-ophthalmologic manifestations.

Authors:  Daniel P Schwartz; Matthew S Robbins
Journal:  Eye Brain       Date:  2012-09-13

Review 3.  Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants.

Authors:  Nikhat J Siddiqi; Maria de Lourdes Pereira; Bechan Sharma
Journal:  Mol Neurobiol       Date:  2022-03-29       Impact factor: 5.590

Review 4.  The revised monoamine hypothesis: mechanism of antidepressant treatment in the context of behavior.

Authors:  V S Rotenberg
Journal:  Integr Physiol Behav Sci       Date:  1994 Apr-Jun

Review 5.  Management of painful diabetic neuropathy.

Authors:  P G Jensen; J R Larson
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

6.  Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery.

Authors:  Gui-Feng Tong; Nan Qin; Li-Wei Sun
Journal:  Saudi Pharm J       Date:  2016-12-23       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.